Concord Wealth Partners Quanterix Corp Transaction History
Concord Wealth Partners
- $710 Million
- Q3 2025
A detailed history of Concord Wealth Partners transactions in Quanterix Corp stock. As of the latest transaction made, Concord Wealth Partners holds 100 shares of QTRX stock, worth $574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$574
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding QTRX
# of Institutions
138Shares Held
35.6MCall Options Held
0Put Options Held
13.8K-
Portolan Capital Management, LLC Boston, MA4.26MShares$24.5 Million1.45% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN4.24MShares$24.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$15.2 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA1.39MShares$8 Million0.38% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $212M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...